A clinical trial comparing a very low carbohydrate MCT oil supplemented diet with standard diet on prognostic biomarkers and indicators related to cachexia in gastric adenocarcinoma patients.

Vice chancellor of research, International Campus, Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•( diagnosis of gastric adenocarcinoma; patients with ECOG performance status of 0 to 4; patients who have not been gastrectomized; blood, liver, and kidney should be functional; patients aged 18 years and older; both genders will be recruited; leucocytes count be over 3000 cell in each mm3 of blood; neutrophil count be over 1500 cubic millimeter of blood; platelets be over 1500 per each cubic millimeter of blood; total bilirubin lower than 3mg/dL; serum creatinine lower than 2mg/dL; serum potassium less than 5 mmol/L). (Exclusion criteria: Patients which live alone during the intervention without others attendance; Diabetes; patients receiving Insulin or other anabolic drugs along with intervention; pyruvate dehydrogenase complex deficiency; and inherited porphyria ; MCT oil consumption until 5 weeks before recruitment in study; Having congestive heart failure; Uncontrolled hypertension. Severe steatorrhea and diarrhea; Gastrointestinal obstruction; Patients which could not resist the intervention for any reason; Frequent incidence of hypoglycemia during first week of intervention).

发起方

Vice chancellor of research, International Campus, Tehran University of Medical Sciences